Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis?

European Journal of Heart Failure

Volumn 7, Issue 6, 2005, Pages 953-957

  Lewin, Jennifer ^a   Ledwidge, Mark ^a   O'Loughlin, Christina ^a   McNally, Clare ^a   McDonald, Ken ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Beta type natriuretic peptide; Clinical deterioration; Clinically stable; Heart failure; Receiver operating characteristic; Systolic dysfunction; Weight gain

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CALCULATION; CONTROLLED STUDY; DETERIORATION; DIAGNOSTIC ACCURACY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT EDUCATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; ROC CURVE; WEIGHT GAIN;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WEIGHT GAIN;

EID: 26644469841     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.06.003     Document Type: Article

References (19)

1. K.M. McDonald, M. Ledwidge, J. Cahill, J. Kelly, P. Quigley, and B. Maurer Elimination of early rehospitalisation in a randomised controlled trial of multidisciplinary care in a high risk elderly heart failure population Eur J Heart Fail 3 2001 209 215
2. N. Gadsboll, P.F. Hoilund-Carlsen, and C.G. Nielsen Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterisation Eur Heart J 10 1989 1017 1028
3. Task Force Report: guidelines for the diagnosis and treatment of chronic heart failure Eur Heart J 22 2001 1527 1560
4. T.A. McDonagh, S. Holmer, I. Raymond, A. Luchner, P. Hildebrant, and H. Dargie NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies Eur J Heart Fail 6 2004 269 274
5. T.A. McDonagh, S.D. Robb, and D.R. Murdoch Biochemical detection of left ventricular systolic dysfunction Lancet 351 1998 9 13
6. T. Tsutamoto, A. Wada, and K. Maeda Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-I Eur Heart J 20 1999 1799 1807
7. A.S. Maisel, P. Krishnasawami, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
8. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and AM. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 9210 2000 1126 1130
9. A.H.B. Wu, A. Smith, S. Wieczorek, J.F. Mather, B. Ducan, and C.M. White Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure Am J Cardiol 92 2003 628 631
10. A.H.B. Wu, and A. Smith Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure Eur J Heart Fail 6 2004 355 358
11. K.M. McDonald, M. Ledwidge, J. Cahill, E. Ryan, M. Ryder, and B. Travers Heart failure management: multidisciplinary care has intrinsic benefit above the optimisation of medical care J Card Fail 8 3 2002 142 148
12. Q. Dao, P. Krishnaswamy, and R. Kazanegra Utility of B-Type Natriuretic Peptide in the diagnosis of congestive heart failure in an urgent care setting J Am Coll Cardiol 37 2001 379 385
13. L.K. Morrison, A. Harrison, and P. Krishnaswamy Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in individuals presenting with dyspnoea J Am Coll Cardiol 39 2002 202 209
14. S.D. Anker, A. Negassa, A.J. Coats, R. Afzal, P.A. Poole-Wilson, and J.N. Cohn Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
15. P. Bettencourt, A. Azevedo, J. Pimenta, F. Frioes, S. Ferreira, and A. Ferreira N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 15 2004 2168 2174
16. J. de Lemos, D. McGuire, and M. Drazner B-type natriuretic peptide in cardiovascular disease Lancet 362 2003 316 322
17. S.C. Lee, T.L. Stevens, and S.M. Sandberg The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient management of heart failure J Card Fail 8 2002 149 154
18. H. Yasue, M. Yoshimura, and H. Sumida Localisation and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
19. M.T. Rademaker, C.J. Charles, and T. Kosoblou Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure Am J Physiol 273 1997 H2372 H2379